GlassScriptPhysician profile
Bradley Kent Weisner
NPI 1619910627
$7,631.64
in general payments reported to CMS, 2019-2025
42 companies · $176 in 2025
The $176 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,368 · 2020: $710 · 2021: $969 · 2022: $1,461 · 2023: $1,879 · 2024: $1,068 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,123.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,089.48 | 2019-2024 | Myrbetriq |
| Endo Pharmaceuticals INC. | $669.36 | 2019-2024 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $515.05 | 2023-2025 | Gemtesa, Orgovyx |
| Coloplast Corp | $485.00 | 2019-2024 | Speedicath, Porges Coloplast |
| Abbvie INC. | $443.32 | 2019-2024 | Lupron Depot, Botox |
| Dendreon Pharmaceuticals LLC | $430.71 | 2019-2024 | Provenge |
| Pfizer INC. | $395.48 | 2019-2024 | |
| Boston Scientific Corporation | $379.69 | 2019-2024 | Lithovue, Ams 800 Artificial Urinary Sphincter, Ams 700 |
| Urogen Pharma, INC. | $330.62 | 2020-2024 | Jelmyto |
| Antares Pharma, INC. | $327.39 | 2019-2023 | Nocdurna, Tlando, Xyosted |
| Urovant Sciences INC | $308.74 | 2021-2022 | |
| Procept Biorobotics Corporation | $275.48 | 2022-2023 | Aquabeam Robotic System |
| Laborie Medical Technologies Corp. | $228.55 | 2022-2024 | Urgent PC Neuromodulation System |
| Neotract INC. | $223.81 | 2019-2020 | |
| Convatec INC. | $177.40 | 2024-2025 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $152.58 | 2023 | Axonics |
| Olympus America INC. | $136.23 | 2023-2025 | Itind System |
| Halozyme INC | $93.17 | 2023 | |
| C. R. Bard, INC. & Subsidiaries | $92.07 | 2019-2024 | Bard Urinary Drainage Bag |
| Ferring Pharmaceuticals INC. | $86.60 | 2019-2024 | Adstiladrin |
| Tolmar, INC. | $83.80 | 2023-2025 | Eligard, Jatenzo |
| Merck Sharp & Dohme LLC | $74.15 | 2021-2024 | Keytruda |
| Progenics Pharmaceuticals, INC. | $69.12 | 2023-2025 | Pylarify |
| Rochester Medical Corporation | $54.54 | 2019 | |
| Smith+Nephew, INC. | $43.28 | 2023-2024 | Stravix Pl, Stravix |
| Therapeuticsmd, INC. | $40.45 | 2019-2020 | |
| Clarus Therapeutics INC. | $38.76 | 2021 | |
| Ambu INC. | $37.06 | 2024 | |
| Zyla Life Sciences, INC. | $36.04 | 2019 | |
| Peerless Surgical INC. | $35.38 | 2023 | |
| Hollister Incorporated | $34.04 | 2022-2023 | Vapro, Onli, Infyna Chic |
| Abc Home Medical Supply, INC. | $33.63 | 2025 | |
| Teleflex LLC | $30.46 | 2022 | |
| Allergan, INC. | $27.38 | 2020 | |
| Acerus Pharmaceuticals Corporation | $26.25 | 2020-2021 | |
| Janssen Biotech, INC. | $24.52 | 2023 | Erleada |
| Myovant Sciences INC. | $23.88 | 2021 | |
| Medtronic, INC. | $21.40 | 2022 | |
| Agiliti Health, INC. | $14.37 | 2020 | |
| Metuchen Pharmaceuticals | $14.32 | 2020 | |
| Endo USA, INC. | $14.16 | 2024 | Aveed, Xiaflex |
| Tolmar Pharmaceuticals, INC. | $13.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Weisner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.